RAC 0.63% $1.59 race oncology ltd

Ann: First patient treated in Bisantrene trial in Israel, page-10

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 266 Posts.
    lightbulb Created with Sketch. 64

    tried to top up yesterday but order not filled...oh well topped up today so still averaging down and nice paper gain today to recover some past losses. Will add if this drifts lower on a lack of news flow. Nothing new here and good that they mention that cannot provide updates during the trial period so we all know why it's quiet.

    FDA approval is dragging on but maybe there questions the current trial will be able to help answer to assist with approval.

    Still intrigued with the partnership between Sheba and MD Anderson

    Cautiously hopeful on this one but will need to remain patient as pointed our by numerous posters.

    I noticed some interest from an OCC holder which is good. Watched that one for a couple of years and it drifted lower for a long time before popping. Hopefully something similar can be replicated with RAC and longer term holders and anyone accumulating will be rewarded for their patience.

 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.